PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
PRDS
Delisted
PRDS was delisted on the 30th of August, 2023.
59 hedge funds and large institutions have $63.9M invested in Pardes Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 23
Holders
59
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$2.98M | |
| 2 | +$1.4M | |
| 3 | +$1.05M | |
| 4 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$874K |
| 5 |
Barclays
London,
United Kingdom
|
+$703K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$1.65M | |
| 3 | -$1.35M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$597K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$594K |